Bli medlem
Bli medlem

Du är här


ContextVision AB : ContextVision AB - Mandatory notification of trade

Stockholm, February 22nd, 2016

Karin Bernadotte, board member and primary insider in ContextVision AB, has on
February 19th, 2016 purchased 3 500 shares in ContextVision AB at a price of
NOK 28,00 per share. Following this transaction, Karin Bernadotte owns 6 500
shares in ContextVision AB.

"The company is in an extremely interesting phase, and I feel very confident
about the ongoing research and the future for ContextVision"
comments Karin Bernadotte.

For inquires please contact CEO Anita Tollstadius;
This information is subject to the disclosure requirements pursuant to the
Norwegian Securities Trading Act.

About ContextVision

ContextVision's cutting-edge technology helps doctors more accurately
interpret medical images, a crucial foundation for better diagnosis and
treatment. An industry pioneer for more than 30 years, the company's
state-of-the-art medical image analysis and enhancement software for 2D/3D/4D
Ultrasound, MRI, X-Ray and Mammography is used by leading equipment
manufacturers worldwide. ContextVision continues to invest heavily in R&D in
order to expand its technology platform.

ContextVision is based in Sweden and listed on the Oslo Stock Exchange under
the ticker COV. For more information, please visit

ContextVision AB - Mandatory notification of trade


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: ContextVision AB via Globenewswire


Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.